What is the recommended workup for hepatic artery stenosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Hepatic Artery Stenosis

Begin with Doppler ultrasound (DUS) as the primary screening tool, followed by CT angiography (CTA) or MR angiography for confirmation, and proceed to conventional angiography only when intervention is planned or diagnosis remains uncertain.

Initial Screening: Doppler Ultrasound

DUS should be performed within 24 hours post-transplant and daily during the first week 1. This is the most cost-effective, non-invasive screening method with excellent sensitivity for detecting hepatic artery stenosis (HAS).

Key DUS Diagnostic Criteria

Look for the "tardus parvus" waveform pattern in the intrahepatic hepatic artery, which indicates upstream stenosis 2, 3:

  • Systolic acceleration time (SAT) >0.08 seconds (prolonged upstroke)
  • Resistive index (RI) <0.55 (reduced resistance)
  • Peak systolic velocity (PSV) >1.0 m/s in the extrahepatic hepatic artery

When both abnormal RI and SAT are present, specificity reaches 96% for significant stenosis 3. The tardus parvus waveform alone has 100% sensitivity and 99.5% specificity for HAS 4.

Important Caveat

DUS has limitations in detecting the exact location and degree of stenosis in the extrahepatic hepatic artery, particularly when vessel tortuosity is present 4.

Confirmatory Imaging: CTA or MRA

Multidetector CT angiography (MDCTA) should be performed when DUS suggests HAS 4. CTA provides:

  • Precise quantification of stenosis severity (>50% is considered significant)
  • Anatomical mapping of the entire splanchnic vasculature
  • Assessment of vessel tortuosity and surgical anatomy
  • Planning information for potential endovascular intervention

MR angiography is an alternative when contrast nephrotoxicity is a concern, though it may have lower sensitivity than CTA for small vessel stenosis 5.

Advanced Imaging: Contrast-Enhanced Ultrasound (CEUS)

Consider CEUS when DUS findings are equivocal or to avoid radiation/nephrotoxic contrast 6. CEUS provides:

  • 91.5% accuracy for detecting HAS
  • Real-time angiographic-like visualization
  • Identification of stenosis location, degree, and type
  • Correction of false-positive color Doppler findings in 15% of cases

CEUS can alter the clinical algorithm by directly suggesting angiography rather than requiring an intermediate CT scan 6.

Definitive Diagnosis: Conventional Angiography

Reserve conventional angiography for cases where:

  • Endovascular intervention is planned
  • Non-invasive imaging is inconclusive
  • Intravascular imaging (optical coherence tomography) is needed to characterize in-stent restenosis 7

Angiography remains the gold standard and allows simultaneous therapeutic intervention 5, 4.

Clinical Context Matters

Post-Transplant Timing

  • Early screening (<14 days): Daily DUS during first week, then as clinically indicated 1
  • Late presentation (>14 days): DUS prompted by clinical suspicion (elevated liver enzymes, biliary complications)

Risk Factors Requiring Enhanced Surveillance

Monitor more closely in patients with 8:

  • DCD (donation after cardiac death) grafts (2.27× increased risk)
  • Vascular reconstruction for donor arterial variation (2.19× increased risk)
  • History of smoking (increases vascular complications) 9

Laboratory Assessment

Check simultaneously with imaging:

  • Liver function tests (AST, ALT, alkaline phosphatase, bilirubin)
  • Coagulation parameters (PT/INR) - important for intervention planning
  • Renal function (creatinine) - guides contrast decisions

Common Pitfalls to Avoid

  1. Don't rely on a single normal DUS - HAS can develop at any time post-transplant; maintain surveillance schedule
  2. Don't perform liver biopsy when vascular complications are suspected - high risk in HAS patients 10
  3. Don't delay imaging when tardus parvus waveform is detected - this pattern has near-perfect predictive value 2
  4. Don't use microbubble contrast routinely with tardus parvus waveform - proceed directly to angiography as it will be needed regardless 2

Algorithmic Approach

  1. Screening DUS → If normal RI (>0.55) and SAT (<0.08 sec): Continue surveillance
  2. Abnormal DUS (tardus parvus pattern) → CTA/MRA for anatomical confirmation
  3. Confirmed stenosis >50% → Conventional angiography with plan for endovascular therapy
  4. Equivocal findings → Consider CEUS before proceeding to angiography

The combination of DUS screening followed by CTA confirmation provides the optimal balance of sensitivity, specificity, and cost-effectiveness 4, 6.

References

Research

Management of hepatic artery thrombosis and stenosis after pediatric liver transplantation: Variability and agreement in management practices.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2025

Research

Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010

Research

Risk factors and management of hepatic artery stenosis post liver transplantation.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.